IKT
Price
$1.17
Change
+$0.02 (+1.74%)
Updated
Sep 27 closing price
PYXS
Price
$3.62
Change
-$0.10 (-2.69%)
Updated
Sep 27 closing price
44 days until earnings call
Ad is loading...

IKT vs PYXS

Header iconIKT vs PYXS Comparison
Open Charts IKT vs PYXSBanner chart's image
Inhibikase Therapeutics
Price$1.17
Change+$0.02 (+1.74%)
Volume$9.16K
CapitalizationN/A
Pyxis Oncology
Price$3.62
Change-$0.10 (-2.69%)
Volume$288.75K
CapitalizationN/A
View a ticker or compare two or three
IKT vs PYXS Comparison Chart
Loading...
IKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
IKT vs. PYXS commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a StrongBuy and PYXS is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (IKT: $1.34 vs. PYXS: $3.44)
Brand notoriety: IKT and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 26% vs. PYXS: 117%
Market capitalization -- IKT: $8.73M vs. PYXS: $215.11M
IKT [@Biotechnology] is valued at $8.73M. PYXS’s [@Biotechnology] market capitalization is $215.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • IKT’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • IKT’s TA Score: 4 bullish, 3 bearish.
  • PYXS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IKT is a better buy in the short-term than PYXS.

Price Growth

IKT (@Biotechnology) experienced а -4.29% price change this week, while PYXS (@Biotechnology) price change was -6.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

IKT is expected to report earnings on Nov 14, 2023.

PYXS is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($215M) has a higher market cap than IKT($8.73M). PYXS YTD gains are higher at: 91.111 vs. IKT (5.512).
IKTPYXSIKT / PYXS
Capitalization8.73M215M4%
EBITDAN/AN/A-
Gain YTD5.51291.1116%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash1.91MN/A-
Total Debt209KN/A-
TECHNICAL ANALYSIS
Technical Analysis
IKTPYXS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
Declines
ODDS (%)
Bearish Trend about 2 months ago
0%
Bearish Trend about 2 months ago
0%
BollingerBands
ODDS (%)
N/A
Bullish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
View a ticker or compare two or three
Ad is loading...
IKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

IKT and

Correlation & Price change

A.I.dvisor tells us that IKT and EVAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and EVAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
-4.29%
EVAX - IKT
31%
Poorly correlated
+3.61%
NTRB - IKT
22%
Poorly correlated
+15.44%
ONCT - IKT
21%
Poorly correlated
-0.51%
PYXS - IKT
21%
Poorly correlated
-9.23%
CDXC - IKT
21%
Poorly correlated
-4.93%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with CTMX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-9.23%
CTMX - PYXS
39%
Loosely correlated
-5.08%
CDXS - PYXS
38%
Loosely correlated
-1.38%
VKTX - PYXS
38%
Loosely correlated
-8.94%
LXRX - PYXS
36%
Loosely correlated
-6.94%
JANX - PYXS
36%
Loosely correlated
-4.19%
More